Pretreatment plasma TGFβ1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 4, 2000, Pages 991-995

  Dickson, Jeanette ^a   Davidson, Susan E ^b   Hunter, Robert D ^b   West, Catharine M L ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Cervix carcinoma; Late effects; Radiation therapy; TGF 1

Indexed keywords

CA 125 ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER CONTROL; CANCER STAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CA-125 ANTIGEN; CARCINOMA, SQUAMOUS CELL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPHOCYTES; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TISSUE POLYPEPTIDE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 0034333174     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00729-X     Document Type: Article

References (32)

1. Molecular and cell biology of TGF-beta
2. Role of elevated plasma transforming growth factor-beta1 levels in wound healing
3. Transforming growth factor-beta and cancer; A love-hate relationship?
4. Transforming growth factor-beta; Possible roles in carcinogenesis
5. Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer
6. Apparent protection from instability of repeat sequences in cancer-related genes in replication error positive gastrointestinal cancers
7. Molecular and cellular basis of radiation fibrosis
8. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis
9. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis
10. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis
11. TGF-beta1 levels in pretreatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
12. Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix [see comments]
13. Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy
14. The intrinsic radiosensitivity of normal and tumour cells
15. Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy
16. A glossary for reporting complications of treatment in gynecological cancers
17. Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix
18. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1
19. Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix
20. High levels of transforming growth factor beta 1 in patients with colorectal cancer; association with disease progression
21. Increased transforming growth factor beta1 plasma level in patients with renal cell carcinoma; a tumor-specific marker?
22. Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients
23. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases
24. Prognostic significance of serum tumour markers in carcinoma of the cervix
25. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer
26. Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma
27. The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma
28. Transforming growth factor beta 1 expression in human colorectal tumours; An independent prognostic marker in a subgroup of poor prognosis patients
29. Plasma TGFbeta levels during radiotherapy with or without carboplatin predicts pneumonitis in stage III non-small cell lung cancer
30. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer
31. Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor